CE Holdings Co.,Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from CE Holdings Co.,Ltd.'s yearly results (2022–2025), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 16% in 3 years; of every extra ¥100 of sales, ¥46 became extra profit. Higher than 90% of Healthcare companies in Japan.
Where ¥100 of sales goes
Latest year (Sep 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
¥107Over the last 3 years, every ¥100 of reported profit came with ¥107 of operating cash.
Lower than 68% of Healthcare companies in Japan.
Self-Funding Ratio
1.2×Over the last 3 years its own operating cash covered its investment spending (capex) 1.2 times.
Lower than 54% of Healthcare companies in Japan.
Cash Locked Ratio
¥14For every ¥100 of sales, ¥14 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥8 tied up three years earlier.
Less money tied up than 52% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Less steady than 55% of Healthcare companies in Japan.
Growth Efficiency Ratio
¥46Sales grew 16% in 3 years; of every extra ¥100 of sales, ¥46 became extra profit.
Higher than 90% of Healthcare companies in Japan.
Asset Productivity Ratio
+16% / +17%In 3 years sales changed by +16% while total assets changed by +17%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
1.4×Debt due within a year is covered 1.4 times by its yearly operating cash.
Higher than 59% of Healthcare companies in Japan.
Cash Cushion Ratio
+12%Cash, after subtracting all debt, equals 12% of its market value (net cash).
Higher than 64% of Healthcare companies in Japan.
Tangible Assets Ratio
92%Of every ¥100 the company owns, ¥92 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 67% of Healthcare companies in Japan.
Tangible Net Worth Ratio
88%Of every ¥100 of net worth, ¥88 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 60% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
CE Holdings Co.,Ltd. owes ¥0.24 for every ¥1 it owns. Net profit rose 1162% in the year to Sep 2025, and grew 38% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Sep 2025.
P/E ratio
16.7Investors pay ¥16.7 for every ¥1 of CE Holdings Co.,Ltd.'s yearly profit, higher than 54% of Healthcare companies in Japan.
P/B ratio
3.34The share price is 3.34 times CE Holdings Co.,Ltd.'s book value per share, higher than 81% of Healthcare companies in Japan.
Market cap
¥27.2 BThe total market value of all of CE Holdings Co.,Ltd.'s shares at today's price (share price × number of shares), larger than 56% of Healthcare companies in Japan. PosiCap size class: Mini Cap.
Net worth (book value)
¥8.2 BWhat CE Holdings Co.,Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥489.55Net worth divided by the number of shares. The share price of ¥1,633 is 3.3 times this, which is the P/B above.
Return on equity (ROE)
20.9%CE Holdings Co.,Ltd. earned 20.9% on its shareholders' money over the last year, higher than 90% of Healthcare companies in Japan.
Owes vs Owns
0.24×CE Holdings Co.,Ltd. owes ¥0.24 for every ¥1 it owns (low), lower than 68% of Healthcare companies in Japan.
Dividend yield
NoneCE Holdings Co.,Ltd. does not currently pay a dividend.
Revenue growth
+9%Revenue rose 9% in the year to Sep 2025, and grew 5% a year on average over 3 years.
Profit growth
+1162%Net profit rose 1162% in the year to Sep 2025, and grew 38% a year on average over 3 years.
Profit margin
9.8%CE Holdings Co.,Ltd. keeps ¥10 of every ¥100 of revenue as net profit.
Cash quality
0.6×Cash from CE Holdings Co.,Ltd.'s business was 0.6× its reported profit in the year to Sep 2025 — less cash came in than the profit reported.
Interest cover
111.2×CE Holdings Co.,Ltd.'s operating profit covered its interest costs 111.2 times in the year to Sep 2025.
Cash vs debt
Net cashCE Holdings Co.,Ltd. held ¥3.1 B more cash than debt (net cash) at Sep 2025.
Questions
What is CE Holdings Co.,Ltd.'s P/E ratio?
Investors pay ¥16.7 for every ¥1 of CE Holdings Co.,Ltd.'s yearly profit, higher than 54% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For CE Holdings Co.,Ltd.: ¥27.2 B ÷ ¥8.2 B (30 Jun 2026) = 3.3.
What is CE Holdings Co.,Ltd.'s return on equity?
CE Holdings Co.,Ltd. earned 20.9% on its shareholders' money over the last year, higher than 90% of Healthcare companies in Japan.
How much does CE Holdings Co.,Ltd. owe compared with what it owns?
CE Holdings Co.,Ltd. owes ¥0.24 for every ¥1 it owns (low), lower than 68% of Healthcare companies in Japan.
Does CE Holdings Co.,Ltd. pay a dividend?
No. CE Holdings Co.,Ltd. does not currently pay a dividend.
Is CE Holdings Co.,Ltd.'s revenue growing?
Revenue rose 9% in the year to Sep 2025, and grew 5% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.